Pralatrexate
6- ((bromométhyl)-2,4-pteridinediamine hydrobromure (52853-40-4)
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide is a potent inhibitor of the enzyme nitroaldolase (EC 1.2.1.22) and has been shown to inhibit cell growth in murine leukemia cells. It is an intermediate of Pralatrexate. Product Name: 6-(Bromomethyl)-2,4-pteridinediamine hydrobromide CAS No.: 52853-40-4 Assay: 98% End Use: Pralatrexate Molecular Formula: C7H8Br2N6 Molecular Weight: 335.99 Shelf Life: 2 Years Package: 25kg/drum
Pralatrexate (52853-40-4) est un médicament utilisé dans le traitement de l' acné.
Pralatrexate, an injectable DHFR inhibitor, was launched for the treatment of patients with relapsed or refractory PTCL. The inhibition of the folate enzymes DHFR and thymidylate synthase is a well-validated method of cancer treatment. Product Name: Pralatrexate CAS No.: 52853-40-4 Assay: 989% Specification: CP, EP, In-house, as required Molecular Formula: C23H23N7O5 Molecular Weight: 477.47 Shelf Life: 2 Years Package: 25kg/drum
